
CSUCI wants Ventura County to be hub for drones
By Tony Biasotti / Friday, October 2nd, 2015 / Columns, Latest news, Technology, Top Stories, West Ventura County / Comments Off on CSUCI wants Ventura County to be hub for drones
			
			This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
European regulators have good news for Amgen on cancer drugs
By Staff Report / Friday, September 25th, 2015 / Health Care & Life Science, Latest news, Technology, Tri-County Public Companies / Comments Off on European regulators have good news for Amgen on cancer drugs
One of the world’s most expensive cancer drugs got conditional approval from European regulators on Sept. 25. Europeans granted Thousand Oaks-based Amgen conditional approval of its rare blood cancer drug Blincyto and gave a positive evaluation of Amgen’s multiple-myeloma drug Kyprolis. Blincyto is an immunotherapy that is designed to treat a rare form of leukemia Read More →

Industry titans ponder future of digital music
By Philip Joens / Friday, September 25th, 2015 / Technology, Top Stories / Comments Off on Industry titans ponder future of digital music
			
			This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Study shows Amgen’s new biosimilar cancer drug safe, effective
By Staff Report / Wednesday, September 23rd, 2015 / Latest news, Technology, Top Stories / Comments Off on Study shows Amgen’s new biosimilar cancer drug safe, effective
Pharmaceuticals Amgen and Allergan announced positive Phase 3 study results of their new drug ABP 215 on Sept. 23. The drug, used to treat lung cancer, is being developed as a biosimilar to Roche Holding AG’s Avastin. ABP 215 showed clinical safety and effectiveness compared to Avastin. “Lung cancer is the leading cause of cancer Read More →

Startups race to find investors at Cal Poly San Luis Obispo Demo Day
By Philip Joens / Friday, September 18th, 2015 / Central Coast, Latest news, Technology, Top Stories / Comments Off on Startups race to find investors at Cal Poly San Luis Obispo Demo Day
			
			This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Industry titans debate future of digital music
By Philip Joens / Wednesday, September 16th, 2015 / Latest news, South Coast, Technology, Top Stories / Comments Off on Industry titans debate future of digital music
			
			Three titans of the music industry had mixed views of the future of digital music and artists’ ability to profit from it during a panel discussion in Santa Barbara Wednesday evening. The MIT Enterprise Forum of the Central Coast featured Tom Conrad, co-founder and retired chief technology officer of Pandora; Marc Geiger, head of the Read More →
Amgen buys biotech company, partners with another
By Staff Report / Wednesday, September 16th, 2015 / Health Care & Life Science, Latest news, Technology, Top Stories, Tri-County Public Companies / Comments Off on Amgen buys biotech company, partners with another
Thousand Oaks-based biopharmaceutical giant Amgen bought a Netherlands-based company and partnered with a Monrovia-based company in an effort to fend off competitors. Amgen announced Sept. 16 that it will buy Dezima, a biotech company focused on developing new treatments for dyslipidemia, a disease where a person has an abnormal amount of lipids in their blood. Read More →
 







